中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2014年
1期
103-104
,共2页
舒芬太尼%右美托嘧啶%妇科%腔镜手术%镇痛
舒芬太尼%右美託嘧啶%婦科%腔鏡手術%鎮痛
서분태니%우미탁밀정%부과%강경수술%진통
Sufentanil%Dexmedetomidine%Gynecology%Laparoscopic surgery%Analgesia
目的：探讨在妇科腔镜手术患者术后镇痛中舒芬太尼复合右美托嘧啶的临床应用价值。方法：选取2012年3月至2013年3月间于我院行妇科腔镜手术治疗的患者122例,按期就诊顺序进行编号并随机分为对照组(61例)和观察组(61例),对照组患者术后行舒芬太尼自控静脉镇痛(PCIA),观察组患者术后行舒芬太尼+右美托嘧啶PCIA,观察两组患者各临床指标,并进行统计学对比分析。结果：观察组患者术后6h、12h、24h、48h疼痛评分均明显低于对照组患者,组间差异在统计学上有意义(P<0.05)；观察组患者术后2d舒芬太尼用量(80.56±17.24)ml、PCA键按压次数(18.23±3.75)次、并发症发生率(1.64%)均明显低于对照组(102.45±19.74)ml、(25.28±3.85)次、(9.84%),而其满意度(91.80%)明显高于对照组(78.69%),以上组间差异在统计学上有意义(P<0.05)。结论：舒芬太尼复合右美托嘧啶在保证妇科腔镜手术术后镇痛效果更佳的情况下,能够减少麻醉药用量、减少并发症发生、提高患者满意度,对于改善患者预后、促进患者病情恢复具有重要意义。
目的：探討在婦科腔鏡手術患者術後鎮痛中舒芬太尼複閤右美託嘧啶的臨床應用價值。方法：選取2012年3月至2013年3月間于我院行婦科腔鏡手術治療的患者122例,按期就診順序進行編號併隨機分為對照組(61例)和觀察組(61例),對照組患者術後行舒芬太尼自控靜脈鎮痛(PCIA),觀察組患者術後行舒芬太尼+右美託嘧啶PCIA,觀察兩組患者各臨床指標,併進行統計學對比分析。結果：觀察組患者術後6h、12h、24h、48h疼痛評分均明顯低于對照組患者,組間差異在統計學上有意義(P<0.05)；觀察組患者術後2d舒芬太尼用量(80.56±17.24)ml、PCA鍵按壓次數(18.23±3.75)次、併髮癥髮生率(1.64%)均明顯低于對照組(102.45±19.74)ml、(25.28±3.85)次、(9.84%),而其滿意度(91.80%)明顯高于對照組(78.69%),以上組間差異在統計學上有意義(P<0.05)。結論：舒芬太尼複閤右美託嘧啶在保證婦科腔鏡手術術後鎮痛效果更佳的情況下,能夠減少痳醉藥用量、減少併髮癥髮生、提高患者滿意度,對于改善患者預後、促進患者病情恢複具有重要意義。
목적：탐토재부과강경수술환자술후진통중서분태니복합우미탁밀정적림상응용개치。방법：선취2012년3월지2013년3월간우아원행부과강경수술치료적환자122례,안기취진순서진행편호병수궤분위대조조(61례)화관찰조(61례),대조조환자술후행서분태니자공정맥진통(PCIA),관찰조환자술후행서분태니+우미탁밀정PCIA,관찰량조환자각림상지표,병진행통계학대비분석。결과：관찰조환자술후6h、12h、24h、48h동통평분균명현저우대조조환자,조간차이재통계학상유의의(P<0.05)；관찰조환자술후2d서분태니용량(80.56±17.24)ml、PCA건안압차수(18.23±3.75)차、병발증발생솔(1.64%)균명현저우대조조(102.45±19.74)ml、(25.28±3.85)차、(9.84%),이기만의도(91.80%)명현고우대조조(78.69%),이상조간차이재통계학상유의의(P<0.05)。결론：서분태니복합우미탁밀정재보증부과강경수술술후진통효과경가적정황하,능구감소마취약용량、감소병발증발생、제고환자만의도,대우개선환자예후、촉진환자병정회복구유중요의의。
Objective:To investigate the clinical value of sufentanil of dexmedetomidine for postoperative analgesia in patients with gynecologic laparoscopic surgery.Methods:Selected gynecological laparoscopic surgery in patients treated 122 cases, regular visits are numbered sequentially and randomly divided into control group(61 cases) and observation group(61 cases),Control patients postoperative sufentanil controlled intravenous analgesia (PCIA),the observation group were postoperative sufentanil+dexmedetomidine PCIA, observed in patients with various clinical indicators and statistically analyzed.Results:The patients 6h, 12h, 24h, 48h pain scores were significantly lower than the control group of patients, the difference between groups was statistically significant(P<0.05);observation group patients 2d sufentanil dosage (80.56±17.24) ml, PCA button pressing times (18.23±3.75) times the complication rate (1.64%) were significantly lower than the control group (102.45±19.74) ml, (25.28±3.85) times (9.84%) and their satisfaction (91.80%) was significantly higher (78.69%), the above difference between the groups was statistically significant (P<0.05).Conclusion:Composite sufentanil right beauty pyrimidine in ensuring better postoperative analgesia after cavity mirror effect, can reduce drug consumption, reduce complications and improve patient satisfaction, to improve patients' prognosis, promote patients recovery is of great significance.
